Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gleave

Showing results (481-490 of 941) with videos related to

Pageof 95
Sort By:
Gates Open Research|April 13, 2026
The mini chamber test: a novel bioassay for bioefficacy testing of chlorfenapyr treated nets used in malaria controlAmy Lewis, Rowan Jones-Brown, Gemma Harvey, et al.
Molecular Cancer Therapeutics|June 8, 2012
Cotargeting stress-activated Hsp27 and autophagy as a combinatorial strategy to amplify endoplasmic reticular stress in prostate cancerMasafumi Kumano, Junya Furukawa, Masaki Shiota, et al.
Molecular Endocrinology (Baltimore, Md.)|June 7, 2012
Expression and function of myometrial PSF suggest a role in progesterone withdrawal and the initiation of laborNing Xie, Liangliang Liu, Yunqing Li, et al.
Molecular Cancer Therapeutics|October 30, 2014
Anticancer activity of a novel selective CYP17A1 inhibitor in preclinical models of castrate-resistant prostate cancerPaul J Toren, Soojin Kim, Steven Pham, et al.
Microrna (Shariqah, United Arab Emirates)|December 4, 2018
Common Variants of the Plant microRNA-168a Exhibit Differing Silencing Efficacy for Human Low-Density Lipoprotein Receptor Adaptor Protein 1 (LDLRAP1)Claudia Lang, Sakuntala Karunairetnam, Kim R Lo, et al.
Lancet (London, England)|May 22, 1971
Progestagens and advanced breast cancerV Jones, C A Joslin, R E Jones, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 14, 2019
A Prospective Study on <sup>18</sup>F-DCFPyL PSMA PET/CT Imaging in Biochemical Recurrence of Prostate CancerEtienne Rousseau, Don Wilson, Frédéric Lacroix-Poisson, et al.
Plos One|March 26, 2014
Prostate stromal cells express the progesterone receptor to control cancer cell mobilityYue Yu, Jennifer Suehyun Lee, Ning Xie, et al.
Cell Death & Disease|October 21, 2011
OGX-427 inhibits tumor progression and enhances gemcitabine chemotherapy in pancreatic cancerV Baylot, C Andrieu, M Katsogiannou, et al.
The Prostate|March 26, 2004
YB-1 is upregulated during prostate cancer tumor progression and increases P-glycoprotein activityPepita Giménez-Bonafé, Matthew N Fedoruk, Tanis G Whitmore, et al.
Pageof 95

Showing results (481-490 of 941) with videos related to

Sort By:
Pageof 95
Gates Open Research|April 13, 2026
The mini chamber test: a novel bioassay for bioefficacy testing of chlorfenapyr treated nets used in malaria controlAmy Lewis, Rowan Jones-Brown, Gemma Harvey, et al.
Molecular Cancer Therapeutics|June 8, 2012
Cotargeting stress-activated Hsp27 and autophagy as a combinatorial strategy to amplify endoplasmic reticular stress in prostate cancerMasafumi Kumano, Junya Furukawa, Masaki Shiota, et al.
Molecular Endocrinology (Baltimore, Md.)|June 7, 2012
Expression and function of myometrial PSF suggest a role in progesterone withdrawal and the initiation of laborNing Xie, Liangliang Liu, Yunqing Li, et al.
Molecular Cancer Therapeutics|October 30, 2014
Anticancer activity of a novel selective CYP17A1 inhibitor in preclinical models of castrate-resistant prostate cancerPaul J Toren, Soojin Kim, Steven Pham, et al.
Microrna (Shariqah, United Arab Emirates)|December 4, 2018
Common Variants of the Plant microRNA-168a Exhibit Differing Silencing Efficacy for Human Low-Density Lipoprotein Receptor Adaptor Protein 1 (LDLRAP1)Claudia Lang, Sakuntala Karunairetnam, Kim R Lo, et al.
Lancet (London, England)|May 22, 1971
Progestagens and advanced breast cancerV Jones, C A Joslin, R E Jones, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 14, 2019
A Prospective Study on <sup>18</sup>F-DCFPyL PSMA PET/CT Imaging in Biochemical Recurrence of Prostate CancerEtienne Rousseau, Don Wilson, Frédéric Lacroix-Poisson, et al.
Plos One|March 26, 2014
Prostate stromal cells express the progesterone receptor to control cancer cell mobilityYue Yu, Jennifer Suehyun Lee, Ning Xie, et al.
Cell Death & Disease|October 21, 2011
OGX-427 inhibits tumor progression and enhances gemcitabine chemotherapy in pancreatic cancerV Baylot, C Andrieu, M Katsogiannou, et al.
The Prostate|March 26, 2004
YB-1 is upregulated during prostate cancer tumor progression and increases P-glycoprotein activityPepita Giménez-Bonafé, Matthew N Fedoruk, Tanis G Whitmore, et al.
Pageof 95